Sex-hormone-iven innate antibodies protect females and infants against EPEC infection.
Prominent Awards Ģ016 Seymour Heisler Memorial Lectureship AwardĢ015 Chair Gairdner Award MAB committees, Member F1000Ģ011 CAG Research Excellence Award LecturerĢ010 Canadian Society Clinical Investigation (CSCI)/Royal College Physicians Surgeons Canada (RCPSC) Henry Friesen AwardĢ010 Canadian Society of Immunology Investigator AwardĢ009 Distinguished Scholar Award, Royal Society of CanadaĢ005 Alberta Science and Technology Award Ģ003 Faculty of Medicine Smith Distinguished Achievement AwardĢ003 American Physiological Society, Henry Pickering Bowditch LectureshipĢ002 Viventia Biotech Distinguished Professor of Immunology LectureshipĢ001 Faculty of Medicine’s Smith Distinguished Achievement Award He has published over 300 peer-reviewed papers in high impact science journals including Cell, Science and Nature Medicine as well as clinical journals like Lancet. Kubes presently holds twelve peer-reviewed grants, six of which are CIHR grants.
Any patient that enters an Alberta ICU enters this program. Kubes runs a training program geared towards elucidating the cellular, molecular, and physiologic mechanisms of infectious and immune disease and a clinical program entitled the AHFMR Alberta Sepsis Network. He operates a translational laboratory that supports critical care clinical trials with molecular lab tests. He is appointed as the Snyder Research Chair in Critical Care Medicine. He holds a Canada Research Chair in Leukocyte Recruitment in Inflammatory Disease. In 2008, Kubes was involved in the founding of the Snyder Institute for Chronic Diseases and has been the founding director of the institute since then. The current primary focus of his lab is to directly visualize the roles of immune cells such as platelets, neutrophils and neutrophil extracellular traps(NETs) during inflammation, infection and sepsis and tissue injury using cutting edge technology, including spinning-disk confocal, resonant-scanning confocal, and multi-photon microscopy.
#FACEBOOK JOHN KUBES CALIFORNIA FULL#
He currently holds a full Professor position at the University of Calgary’s Faculty of Medicine, Department of Physiology and Pharmacology. Since then he has branched his field of research to understand leukocyte recruitment in various models of inflammatory disease in various tissues including the brain, liver and the gut. Kubes and his team identified that an endogenously produced gas, nitric oxide, functions to reduce leukocyte recruitment and that inhaled NO can be used as a potential therapy for excessive inflammation during ischemia. Here he continued to study the mechanisms that lead to recruitment of leukocytes in cardiovascular diseases. He returned to Canada in 1991 as Assistant Professor at the University of Calgary. He developed a system to visualize the behaviour of leukocytes in blood vessels under normal conditions and heart conditions like an ischemic episode in the heart. His research involved studying the excessive inflammation associated with heart attacks and strokes. Then, under the supervision of Chris Chapler, he completed his MSc in 1986 and PhD degree in 1988 in the area of Cardiovascular Physiology.Īfter his Ph.D., he went on to work with Neil Granger at Louisiana State University ( Medical Center on a post-doctoral fellowship in 1988. He completed his BScHons in 1984 under the guidance of. Kubes received his college degree in 1981 from John Abbott College, Quebec, Canada in Health Science and his BscHons, MSc and PhD degrees from Queen's University, Ontario, Canada.
0 kommentar(er)
